Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rhida Bautista"'
Autor:
Auro Viswabandya, Jeffrey H. Lipton, Armin Gerbitz, Rhida Bautista, Arjun Datt Law, Dennis Dong Hwan Kim, Fotios V. Michelis, Wilson Lam, Ivan Pasic, Rajat Kumar, Jonas Mattsson, Eshrak Al-Shaibani, Zeyad Al-Shaibani
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:e327-e334
Background: Allogeneic hematopoietic cell transplantation (HCT) is potentially curative for hematological disease however can be complicated by relapse or graft failure (GF), for which second-HCT and donor lymphocyte infusions (DLI) are performed. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::668ea4fa37c5b427852f0291553dd504
https://doi.org/10.1016/j.clml.2021.11.004
https://doi.org/10.1016/j.clml.2021.11.004
Autor:
Arjun Datt Law, Dennis Dong Hwan Kim, Jonas Mattsson, Zeyad‐Al Shaibani, Fotios V. Michelis, Jeffrey H. Lipton, Wilson Lam, Maria Queralt Salas, Eshetu G. Atenafu, Rajat Kumar, Auro Viswabandya, Shruti Prem, Maria Rhida Bautista
Publikováno v:
European Journal of Haematology. 104:36-45
Objectives Haploidentical hematopoietic stem cell transplant (haplo-SCT) has been associated with higher rates of graft rejection, and a higher dose of CD34+ cell dose is frequently requested. We aim to explore the impact of CD34+ cell dose in periph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b08a39b002eff885f484f82579335d9
https://doi.org/10.1111/ejh.13332
https://doi.org/10.1111/ejh.13332
Autor:
Wilson Lam, Jonas Mattsson, Shruti Prem, Jose Avena, Fotios V. Michelis, Eshetu G. Atenafu, Rhida Bautista, Jeffrey H. Lipton, Rajat Kumar, Arjun Law, Auro Viswabandya, Dennis Dong Hwan Kim
Publikováno v:
European journal of haematologyREFERENCES. 103(5)
Objective The primary objective was to assess the effect of central nervous system involvement in acute myeloid leukemia (CNS-AML) on outcomes after allogeneic hematopoietic stem cell transplant (allo-HCT). The secondary objective was to assess the u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b40b0ebc0af0a6633da0f104b22f85a5
https://pubmed.ncbi.nlm.nih.gov/31418930
https://pubmed.ncbi.nlm.nih.gov/31418930
Autor:
Hans A. Messner, Auro Viswabandya, Fotios V. Michelis, Maria Rhida Bautista, Dennis Dong Hwan Kim, Wilson Lam, Santhosh Thyagu, Rajat Kumar, Arjun Law, Jeffrey H. Lipton
Publikováno v:
Blood. 132:3403-3403
BACKGROUND: Systemic immunosuppression (SIS) is the standard treatment for significant acute and chronic graft versus host disease (GVHD) after allogeneic hematopoietic cell transplantation (HCT). Previous studies have shown that 30-70% of patients r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38795443977c6ca87c2d9b48662b3d62
https://doi.org/10.1182/blood-2018-99-119472
https://doi.org/10.1182/blood-2018-99-119472
Autor:
Cecilia Jimeno, Rhida Bautista, Maria Vanessa C. Villarruz, Gwyneth Giselle B. Velez, Joel Chua, Mark Anthony U. Javelosa, Antonio Miguel L. Dans
Publikováno v:
Journal of Clinical Epidemiology. 60:554-559
Background and Objectives Momordica charantia , locally known as Ampalaya, is being widely used and advertised for its hypoglycemic effects. However, to date, no large clinical trial has been published on the efficacy of any type of preparation. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::544a534add9fc47f766ac317b123fef3
https://doi.org/10.1016/j.jclinepi.2006.07.009
https://doi.org/10.1016/j.jclinepi.2006.07.009